The single-chain form of tissue-type plasminogen activator has catalytic activity: Studies with a mutant enzyme that lacks the cleavage site

Jeri Ann Boose, Esa Kuismanen, Robert Gerard, Joe Sambrook, Mary Jane Gething

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Tissue-type plasminogen activator (t-PA), the serine protease responsible for catalyzing the production of plasmin from plasminogen at the site of blood clots, is synthesized as a single-chain polypeptide precursor. Proteolytic cleavage at the C-terminal side of Arg275 generates a two-chain form of the enzyme whose subunits are held together by a single disulfide bond. We have measured the activities of both forms of the wild-type enzyme, as well as that of a mutant enzyme (Arg275 → Gly), created by oligonucleotide-directed mutagenesis, that cannot be cleaved into a two-chain form. Both types of single-chain t-PAs are enzymatically active and exhibit identical Vmax and Km values when assayed with synthetic peptide substrates, indicating that the single amino acid change had no effect on the amidolytic activity of the enzyme. However, cleavage of wild-type t-PA into the two-chain form results in increased activity both on a peptide substrate and on the natural substrates Lys- and Glu-plasminogen in the absence or presence of stimulation by soluble fibrin. The enhanced activity is due to a 3-5-fold increase in the Vmax of the cleaved enzyme, rather than to any change in the Km values for the various substrates. During incubation with plasminogen, the single-chain form of wild-type t-PA is converted to the two-chain form by plasmin generated during the reaction. This conversion, from the less active to the more active form of the enzyme, results in a reaction that displays biphasic kinetics. Both the single-chain, cleavage-minus t-PA and the two-chain, wild-type t-PA are stimulated by soluble fibrin, although the single-chain form requires higher levels of fibrin to achieve maximum activity. Finally, both forms of the enzyme can be inhibited to the same extent by the serpin plasminogen activator inhibitor 1 (PAI-1).

Original languageEnglish (US)
Pages (from-to)635-643
Number of pages9
JournalBiochemistry
Volume28
Issue number2
StatePublished - 1989

Fingerprint

Tissue Plasminogen Activator
Catalyst activity
Plasminogen Activators
Enzymes
Plasminogen
Fibrin
Fibrinolysin
Substrates
Peptides
Serpins
Mutagenesis
Plasminogen Activator Inhibitor 1
Serine Proteases
Site-Directed Mutagenesis
Oligonucleotides
Disulfides
Thrombosis
Blood
Amino Acids
Kinetics

ASJC Scopus subject areas

  • Biochemistry

Cite this

The single-chain form of tissue-type plasminogen activator has catalytic activity : Studies with a mutant enzyme that lacks the cleavage site. / Boose, Jeri Ann; Kuismanen, Esa; Gerard, Robert; Sambrook, Joe; Gething, Mary Jane.

In: Biochemistry, Vol. 28, No. 2, 1989, p. 635-643.

Research output: Contribution to journalArticle

Boose, JA, Kuismanen, E, Gerard, R, Sambrook, J & Gething, MJ 1989, 'The single-chain form of tissue-type plasminogen activator has catalytic activity: Studies with a mutant enzyme that lacks the cleavage site', Biochemistry, vol. 28, no. 2, pp. 635-643.
Boose, Jeri Ann ; Kuismanen, Esa ; Gerard, Robert ; Sambrook, Joe ; Gething, Mary Jane. / The single-chain form of tissue-type plasminogen activator has catalytic activity : Studies with a mutant enzyme that lacks the cleavage site. In: Biochemistry. 1989 ; Vol. 28, No. 2. pp. 635-643.
@article{d7eeff808851494a96cfc33e7be9bc95,
title = "The single-chain form of tissue-type plasminogen activator has catalytic activity: Studies with a mutant enzyme that lacks the cleavage site",
abstract = "Tissue-type plasminogen activator (t-PA), the serine protease responsible for catalyzing the production of plasmin from plasminogen at the site of blood clots, is synthesized as a single-chain polypeptide precursor. Proteolytic cleavage at the C-terminal side of Arg275 generates a two-chain form of the enzyme whose subunits are held together by a single disulfide bond. We have measured the activities of both forms of the wild-type enzyme, as well as that of a mutant enzyme (Arg275 → Gly), created by oligonucleotide-directed mutagenesis, that cannot be cleaved into a two-chain form. Both types of single-chain t-PAs are enzymatically active and exhibit identical Vmax and Km values when assayed with synthetic peptide substrates, indicating that the single amino acid change had no effect on the amidolytic activity of the enzyme. However, cleavage of wild-type t-PA into the two-chain form results in increased activity both on a peptide substrate and on the natural substrates Lys- and Glu-plasminogen in the absence or presence of stimulation by soluble fibrin. The enhanced activity is due to a 3-5-fold increase in the Vmax of the cleaved enzyme, rather than to any change in the Km values for the various substrates. During incubation with plasminogen, the single-chain form of wild-type t-PA is converted to the two-chain form by plasmin generated during the reaction. This conversion, from the less active to the more active form of the enzyme, results in a reaction that displays biphasic kinetics. Both the single-chain, cleavage-minus t-PA and the two-chain, wild-type t-PA are stimulated by soluble fibrin, although the single-chain form requires higher levels of fibrin to achieve maximum activity. Finally, both forms of the enzyme can be inhibited to the same extent by the serpin plasminogen activator inhibitor 1 (PAI-1).",
author = "Boose, {Jeri Ann} and Esa Kuismanen and Robert Gerard and Joe Sambrook and Gething, {Mary Jane}",
year = "1989",
language = "English (US)",
volume = "28",
pages = "635--643",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - The single-chain form of tissue-type plasminogen activator has catalytic activity

T2 - Studies with a mutant enzyme that lacks the cleavage site

AU - Boose, Jeri Ann

AU - Kuismanen, Esa

AU - Gerard, Robert

AU - Sambrook, Joe

AU - Gething, Mary Jane

PY - 1989

Y1 - 1989

N2 - Tissue-type plasminogen activator (t-PA), the serine protease responsible for catalyzing the production of plasmin from plasminogen at the site of blood clots, is synthesized as a single-chain polypeptide precursor. Proteolytic cleavage at the C-terminal side of Arg275 generates a two-chain form of the enzyme whose subunits are held together by a single disulfide bond. We have measured the activities of both forms of the wild-type enzyme, as well as that of a mutant enzyme (Arg275 → Gly), created by oligonucleotide-directed mutagenesis, that cannot be cleaved into a two-chain form. Both types of single-chain t-PAs are enzymatically active and exhibit identical Vmax and Km values when assayed with synthetic peptide substrates, indicating that the single amino acid change had no effect on the amidolytic activity of the enzyme. However, cleavage of wild-type t-PA into the two-chain form results in increased activity both on a peptide substrate and on the natural substrates Lys- and Glu-plasminogen in the absence or presence of stimulation by soluble fibrin. The enhanced activity is due to a 3-5-fold increase in the Vmax of the cleaved enzyme, rather than to any change in the Km values for the various substrates. During incubation with plasminogen, the single-chain form of wild-type t-PA is converted to the two-chain form by plasmin generated during the reaction. This conversion, from the less active to the more active form of the enzyme, results in a reaction that displays biphasic kinetics. Both the single-chain, cleavage-minus t-PA and the two-chain, wild-type t-PA are stimulated by soluble fibrin, although the single-chain form requires higher levels of fibrin to achieve maximum activity. Finally, both forms of the enzyme can be inhibited to the same extent by the serpin plasminogen activator inhibitor 1 (PAI-1).

AB - Tissue-type plasminogen activator (t-PA), the serine protease responsible for catalyzing the production of plasmin from plasminogen at the site of blood clots, is synthesized as a single-chain polypeptide precursor. Proteolytic cleavage at the C-terminal side of Arg275 generates a two-chain form of the enzyme whose subunits are held together by a single disulfide bond. We have measured the activities of both forms of the wild-type enzyme, as well as that of a mutant enzyme (Arg275 → Gly), created by oligonucleotide-directed mutagenesis, that cannot be cleaved into a two-chain form. Both types of single-chain t-PAs are enzymatically active and exhibit identical Vmax and Km values when assayed with synthetic peptide substrates, indicating that the single amino acid change had no effect on the amidolytic activity of the enzyme. However, cleavage of wild-type t-PA into the two-chain form results in increased activity both on a peptide substrate and on the natural substrates Lys- and Glu-plasminogen in the absence or presence of stimulation by soluble fibrin. The enhanced activity is due to a 3-5-fold increase in the Vmax of the cleaved enzyme, rather than to any change in the Km values for the various substrates. During incubation with plasminogen, the single-chain form of wild-type t-PA is converted to the two-chain form by plasmin generated during the reaction. This conversion, from the less active to the more active form of the enzyme, results in a reaction that displays biphasic kinetics. Both the single-chain, cleavage-minus t-PA and the two-chain, wild-type t-PA are stimulated by soluble fibrin, although the single-chain form requires higher levels of fibrin to achieve maximum activity. Finally, both forms of the enzyme can be inhibited to the same extent by the serpin plasminogen activator inhibitor 1 (PAI-1).

UR - http://www.scopus.com/inward/record.url?scp=0024532410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024532410&partnerID=8YFLogxK

M3 - Article

C2 - 2496749

AN - SCOPUS:0024532410

VL - 28

SP - 635

EP - 643

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 2

ER -